{"Q": 1, "answer": "no", "rationale": "No intensifier or comparative adjective directly modifies a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_5724", "batch_size": 200, "batch_pos": 85, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment uses neutral language like 'too early to tell how many doses'.", "method": "llm_batch", "batch_id": "batch_2_14192", "batch_size": 200, "batch_pos": 44, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment does not contain a moderate verb paired with significant scale or impact.", "method": "llm_batch", "batch_id": "batch_3_732", "batch_size": 200, "batch_pos": 195, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment contains no loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_11276", "batch_size": 200, "batch_pos": 184, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The quoted source reports a factual status ('too early to tell') without explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_19260", "batch_size": 200, "batch_pos": 176, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "No minimiser + scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_15168", "batch_size": 200, "batch_pos": 135, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "No bare negation found.", "method": "llm_batch", "batch_id": "batch_7_11256", "batch_size": 200, "batch_pos": 124, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "The segment describes uncertainty about a capability ('too early to tell how many doses... will be able to manufacture') without active reassurance.", "method": "llm_batch", "batch_id": "batch_8_7888", "batch_size": 200, "batch_pos": 171, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
